Back
Bone Biologics 10K Form
Sell
7
BBLG
Bone Biologics
Last Price:
1.32
Seasonality Move:
-33.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBLG News And Ratings
See the #1 stock for the next 7 days that we like better than BBLG
BBLG Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-895.9K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.21 |
| Price / Book: | 0.74 |
Profitability
| EPS (TTM): | -9.76110 |
|---|---|
| Net Income (TTM): | $-5.12M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Bone Biologics Earnings Forecast
Key Bone Biologics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 10 years have been positive in 6 years.
Bone Biologics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BBLG |
| Website: | bonebiologics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BBLG Technical Analysis vs Fundamental Analysis
Sell
7
Bone Biologics (BBLG)
is a Sell
Is Bone Biologics a Buy or a Sell?
-
Bone Biologics stock is rated a Sell
The current Bone Biologics [BBLG] share price is $1.18. The Score for BBLG is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.